Article Text

Download PDFPDF

Remarkably similar response to gold therapy in HLA identical sibs with rheumatoid arthritis.
  1. L B van de Putte,
  2. F Speerstra,
  3. P L van Riel,
  4. A M Boerbooms,
  5. P J van't Pad Bosch,
  6. P Reekers


    Two pairs of sibs with definite rheumatoid arthritis responded in a remarkably similar way to parenteral gold therapy, in terms of both toxicity and efficacy. Both pairs proved to be HLA identical. One of the pairs possessed the HLA antigens B8 and DR3, which have been associated with both drug toxicity and excellent clinical response. The other pair did not possess either of these antigens, suggesting that the reaction to gold therapy in patients with rheumatoid arthritis may be determined by other HLA or genetic factors coded for by chromosome 6, or both.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.